Alithea Genomics closed CHF 2.8 million in a seed financing extension led by Novalis Biotech to expand manufacturing capacity and establish a subsidiary in the United States.
Amount Raised
$2.8 Million
Round Type
Seed
LausanneManufacturingBiotechnologyHealth CareInvestors
Description
Alithea Genomics, a leader in large-scale RNA sequencing and transcriptomics, announced the closing of a CHF 2.8 million extension to its seed financing. The round was led by the Novalis Biotech Acceleration fund and included new investor TechU Ventures alongside existing investors. The proceeds will be used to continue commercialization and expand manufacturing capacity of its unique RNA sequencing products, advance the development of new technologies and establish a subsidiary in the United States.
Quick answer
Alithea Genomics raised $2.8 Million in a Seed round, dated March 14, 2024. Investors: Tech U Ventures and Novalis Biotech. Alithea Genomics is based in Lausanne, Vaud, Switzerland.
- How much did Alithea Genomics raise?
- Alithea Genomics raised $2.8 Million in a Seed round on March 14, 2024.
- Who invested in Alithea Genomics?
- Tech U Ventures and Novalis Biotech are named as investors in this round.
- What does Alithea Genomics do?
- Alithea Genomics is a Switzerland-based startup specializing in manufacturing ribonucleic acid (RNA) sequencing products to study gene expressions of cells, with a focus on cancer research.
- Where is Alithea Genomics based and how big is it?
- Alithea Genomics is based in Lausanne, Vaud, Switzerland.
- Who are the decision-makers at Alithea Genomics?
- Fundz holds 1 contact at Alithea Genomics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Alithea Genomics that raised within 45 days of this round, from Fundz verified event records.
- Nami Surgical raised $123K (Pre-Seed) on April 22, 2024.
- Harvard Apparatus Regenerative Technology raised $1.5M on April 15, 2024.
- OsseoLabs raised $2M (Series A) on April 15, 2024.
- 22nd Century raised $4.2M (Seed) on April 8, 2024.
- Neurovalens raised $2.7M (Seed) on April 8, 2024.
- ViaLase raised $38M on March 25, 2024.
Who to call at Alithea Genomics, and when
A new round usually means Alithea Genomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alithea Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alithea Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alithea Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alithea Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alithea Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.